| Challenge: | For flu studies, it is critical to meet enrollment goals during one season. Flu studies with high-enrollment requirements may have just days or weeks to meet their goals. Failure to meet enrollment goals may cause a significant delay until the next flu season. |
| Outcome: | During the initial study planning phase, PharmaNet’s Infectious Disease team implemented proactive strategies to decrease the study start-up time to less than one month. These strategies included site identification, site recruitment, and site training. The team was extremely successful in enrolling 1200 subjects who were vaccinated for flu during a 4.5-week enrollment period. |
 |
||
 |
In Phase II-IV PharmaNet offers all the clinical development services traditionally associated with conducting Phase II-IV programs. A key differentiating factor of PharmaNet is that in every program we conduct, PharmaNet provides an unrivaled combination of experienced project-management teams, senior management oversight, and an exclusive approach to building relationships with sponsors. |
 |
 |
||
Overcoming a Short Enrollment Period in a Seasonal-Flu Study
PharmaNet Development Group, Inc.
504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390
504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390
© 2008 PharmaNet Development Group, Inc. All rights reserved.